AMLX Annual Total Long Term Liabilities
$1.98 M
-$2.26 M-53.27%
31 December 2023
Summary:
As of January 23, 2025, AMLX annual total long term liabilities is $1.98 million, with the most recent change of -$2.26 million (-53.27%) on December 31, 2023. During the last 3 years, it has fallen by -$71.52 million (-97.31%). AMLX annual total long term liabilities is now -99.17% below its all-time high of $239.39 million, reached on December 31, 2021.AMLX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMLX Quarterly Long Term Liabilities
$595.00 K
-$177.00 K-22.93%
30 September 2024
Summary:
As of January 23, 2025, AMLX quarterly total long term liabilities is $595.00 thousand, with the most recent change of -$177.00 thousand (-22.93%) on September 30, 2024. Over the past year, it has dropped by -$1.97 million (-76.82%). AMLX quarterly long term liabilities is now -99.75% below its all-time high of $239.39 million, reached on December 31, 2021.AMLX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMLX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.3% | -76.8% |
| 3 y3 years | -97.3% | -76.8% |
| 5 y5 years | -91.8% | -76.8% |
AMLX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.2% | at low | -99.8% | at low |
| 5 y | 5-year | -99.2% | at low | -99.8% | at low |
| alltime | all time | -99.2% | at low | -99.8% | at low |
Amylyx Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $595.00 K(-22.9%) |
| June 2024 | - | $772.00 K(-44.1%) |
| Mar 2024 | - | $1.38 M(-30.2%) |
| Dec 2023 | $1.98 M(-53.3%) | $1.98 M(-22.9%) |
| Sept 2023 | - | $2.57 M(-18.3%) |
| June 2023 | - | $3.14 M(-15.0%) |
| Mar 2023 | - | $3.69 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $4.24 M(-98.2%) | $4.24 M(-11.1%) |
| Sept 2022 | - | $4.77 M(-9.8%) |
| June 2022 | - | $5.29 M(-8.6%) |
| Mar 2022 | - | $5.79 M(-97.6%) |
| Dec 2021 | $239.39 M(+225.7%) | $239.39 M(+0.0%) |
| Sept 2021 | - | $239.38 M(+225.7%) |
| Dec 2020 | $73.50 M(+205.7%) | $73.50 M |
| Dec 2019 | $24.05 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Amylyx Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Amylyx Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AMLX is $1.98 M
What is the all time high annual total long term liabilities for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual total long term liabilities is $239.39 M
What is Amylyx Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AMLX annual total long term liabilities has changed by -$2.26 M (-53.27%)
What is Amylyx Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AMLX is $595.00 K
What is the all time high quarterly long term liabilities for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly total long term liabilities is $239.39 M
What is Amylyx Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AMLX quarterly total long term liabilities has changed by -$1.97 M (-76.82%)